Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van der Ley

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Infection and Immunity|September 22, 2006
Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussisJeroen Geurtsen, Liana Steeghs, Hendrik-Jan Hamstra, et al.
Cellular Microbiology|October 23, 2002
Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activityLiana Steeghs, Mariska Berns, Jan ten Hove, et al.
Microbes and Infection|July 11, 2006
A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidisPeter van Ulsen, Ben Adler, Peter Fassler, et al.
Vaccine|August 18, 2006
Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable regionJeroen Kortekaas, Annika Pettersson, Jenny van der Biezen, et al.
Infection and Immunity|October 24, 2003
Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation formThomas A Luijkx, Harry van Dijken, Hendrik-Jan Hamstra, et al.
Vaccine|May 21, 2010
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification processBas van de Waterbeemd, Mathieu Streefland, Peter van der Ley, et al.
Vaccine|September 15, 2004
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteinsMarien I de Jonge, Hendrik Jan Hamstra, Wim Jiskoot, et al.
Clinical and Vaccine Immunology : CVI|August 25, 2006
Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applicationsMohamed El Khattabi, Hendrik Adams, Erik Heezius, et al.
Infection and Immunity|May 5, 2010
The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal diseaseFloris Fransen, Hendrik Jan Hamstra, Claire J Boog, et al.
The Journal of Biological Chemistry|October 31, 2007
A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophagesJeroen Geurtsen, Eline Angevaare, Marlieke Janssen, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Infection and Immunity|September 22, 2006
Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussisJeroen Geurtsen, Liana Steeghs, Hendrik-Jan Hamstra, et al.
Cellular Microbiology|October 23, 2002
Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activityLiana Steeghs, Mariska Berns, Jan ten Hove, et al.
Microbes and Infection|July 11, 2006
A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidisPeter van Ulsen, Ben Adler, Peter Fassler, et al.
Vaccine|August 18, 2006
Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable regionJeroen Kortekaas, Annika Pettersson, Jenny van der Biezen, et al.
Infection and Immunity|October 24, 2003
Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation formThomas A Luijkx, Harry van Dijken, Hendrik-Jan Hamstra, et al.
Vaccine|May 21, 2010
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification processBas van de Waterbeemd, Mathieu Streefland, Peter van der Ley, et al.
Vaccine|September 15, 2004
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteinsMarien I de Jonge, Hendrik Jan Hamstra, Wim Jiskoot, et al.
Clinical and Vaccine Immunology : CVI|August 25, 2006
Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applicationsMohamed El Khattabi, Hendrik Adams, Erik Heezius, et al.
Infection and Immunity|May 5, 2010
The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal diseaseFloris Fransen, Hendrik Jan Hamstra, Claire J Boog, et al.
The Journal of Biological Chemistry|October 31, 2007
A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophagesJeroen Geurtsen, Eline Angevaare, Marlieke Janssen, et al.
Pageof 8